GENERAL QUALITY TOPICS

In the face of these regulatory transformations, pharmaceutical companies must adapt and prepare diligently for pre-approval plant inspections. MEDVACON, a trusted pharmaceutical consulting firm, stands as a strong partner, offering an array of services designed to assist companies in achieving and maintaining FDA compliance. MEDVACON’s services align seamlessly with the new FDA guidance: The evolving […]

The United States Food and Drug Administration (FDA) has always maintained rigorous standards for pharmaceutical manufacturing practices to ensure the safety and efficacy of drugs. Recently, the FDA has introduced new guidance concerning pre-approval plant inspections, setting forth a framework that will significantly impact pharmaceutical companies’ processes. In this blog, we will delve into the

The QMM Program has far-reaching implications for the life sciences industry: How MEDVACON Can Help Companies with QMM Navigating the QMM Program and achieving higher maturity levels in quality management can be complex. MEDVACON, with its expertise in quality management systems, regulatory compliance, and life sciences industry knowledge, is well-equipped to assist companies in this